197 related articles for article (PubMed ID: 31254535)
1. Simultaneous use of natural adjuvants and cell penetrating peptides improves HCV NS3 antigen-specific immune responses.
Alizadeh S; Irani S; Bolhassani A; Sadat SM
Immunol Lett; 2019 Aug; 212():70-80. PubMed ID: 31254535
[TBL] [Abstract][Full Text] [Related]
2. [The combined application of nucleotide and amino acid sequences of NS3 hepatitis C virus protein, DNA encoding granulocyte macrophage colony-stimulating factor and inhibitor of regulatory T cells induces effective immune response against hepatitis C virus].
Masalova OV; Lesnova EI; Shingarova LN; Tunitskaia VL; Ulanova TI; Burkov AN; Kushch AA
Mol Biol (Mosk); 2012; 46(3):525-34. PubMed ID: 22888642
[TBL] [Abstract][Full Text] [Related]
3. A Multiantigenic DNA Vaccine That Induces Broad Hepatitis C Virus-Specific T-Cell Responses in Mice.
Gummow J; Li Y; Yu W; Garrod T; Wijesundara D; Brennan AJ; Mullick R; Voskoboinik I; Grubor-Bauk B; Gowans EJ
J Virol; 2015 Aug; 89(15):7991-8002. PubMed ID: 26018154
[TBL] [Abstract][Full Text] [Related]
4. Humoral and CD4(+) T helper (Th) cell responses to the hepatitis C virus non-structural 3 (NS3) protein: NS3 primes Th1-like responses more effectively as a DNA-based immunogen than as a recombinant protein.
Lazdina U; Hultgren C; Frelin L; Chen M; Lodin K; Weiland O; Leroux-Roels G; Quiroga JA; Peterson DL; Milich DR; Sällberg M
J Gen Virol; 2001 Jun; 82(Pt 6):1299-1308. PubMed ID: 11369873
[TBL] [Abstract][Full Text] [Related]
5. Enhanced and sustained CD8+ T cell responses with an adenoviral vector-based hepatitis C virus vaccine encoding NS3 linked to the MHC class II chaperone protein invariant chain.
Mikkelsen M; Holst PJ; Bukh J; Thomsen AR; Christensen JP
J Immunol; 2011 Feb; 186(4):2355-64. PubMed ID: 21257961
[TBL] [Abstract][Full Text] [Related]
6. Priming with two DNA vaccines expressing hepatitis C virus NS3 protein targeting dendritic cells elicits superior heterologous protective potential in mice.
Guan J; Deng Y; Chen H; Yin X; Yang Y; Tan W
Arch Virol; 2015 Oct; 160(10):2517-24. PubMed ID: 26215441
[TBL] [Abstract][Full Text] [Related]
7. A novel combined vaccine candidate containing epitopes of HCV NS3, core and E1 proteins induces multi-specific immune responses in BALB/c mice.
Zeng R; Li G; Ling S; Zhang H; Yao Z; Xiu B; He F; Huang R; Wei L
Antiviral Res; 2009 Oct; 84(1):23-30. PubMed ID: 19646486
[TBL] [Abstract][Full Text] [Related]
8. [Immunogenicity and heterologous protection in mice with a recombinant adenoviral-based vaccine carrying a hepatitis C virus truncated NS3 and core fusion protein].
Guan J; Deng Y; Chen H; Yang Y; Wen B; Tan W
Bing Du Xue Bao; 2015 Jan; 31(1):7-13. PubMed ID: 25997323
[TBL] [Abstract][Full Text] [Related]
9. Immunization with a Recombinant Expression Vector Encoding NS3/NS4A of Hepatitis C Virus Genotype 3a Elicits Cell-Mediated Immune Responses in C57BL/6 Mice.
Behzadi MA; Alborzi A; Kalani M; Pouladfar G; Dianatpour M; Ziyaeyan M
Viral Immunol; 2016 Apr; 29(3):138-47. PubMed ID: 26909520
[TBL] [Abstract][Full Text] [Related]
10. [Enhancement of the immune response in mice with a noval HCV DNA vaccine targeting NS3 to dendritic cells].
Yin X; Wang W; Tan WJ; Deng Y; Guan J; Wen B; Chen H; Ruan L
Bing Du Xue Bao; 2011 Jan; 27(1):44-9. PubMed ID: 21462505
[TBL] [Abstract][Full Text] [Related]
11. Induction of antigen-specific immune responses in vivo after vaccination with dendritic cells transduced with adenoviral vectors encoding hepatitis C virus NS3.
Xiang M; Eisenbach C; Lupu CM; Ernst E; Stremmel W; Encke J
Viral Immunol; 2006; 19(2):210-9. PubMed ID: 16817764
[TBL] [Abstract][Full Text] [Related]
12. Induction of potent cellular immune response in mice by hepatitis C virus NS3 protein with double-stranded RNA.
Jin B; Wang RY; Qiu Q; Sugauchi F; Grandinetti T; Alter HJ; Shih JW
Immunology; 2007 Sep; 122(1):15-27. PubMed ID: 17451465
[TBL] [Abstract][Full Text] [Related]
13. Oral Combination Vaccine, Comprising Bifidobacterium Displaying Hepatitis C Virus Nonstructural Protein 3 and Interferon-α, Induces Strong Cellular Immunity Specific to Nonstructural Protein 3 in Mice.
Kitagawa K; Omoto C; Oda T; Araki A; Saito H; Shigemura K; Katayama T; Hotta H; Shirakawa T
Viral Immunol; 2017 Apr; 30(3):196-203. PubMed ID: 28112593
[TBL] [Abstract][Full Text] [Related]
14. Induction of Genotype Cross-Reactive, Hepatitis C Virus-Specific, Cell-Mediated Immunity in DNA-Vaccinated Mice.
Wijesundara DK; Gummow J; Li Y; Yu W; Quah BJ; Ranasinghe C; Torresi J; Gowans EJ; Grubor-Bauk B
J Virol; 2018 Apr; 92(8):. PubMed ID: 29437963
[TBL] [Abstract][Full Text] [Related]
15. A non-human hepadnaviral adjuvant for hepatitis C virus-based genetic vaccines.
Levander S; Sällberg M; Ahlén G; Frelin L
Vaccine; 2016 May; 34(25):2821-33. PubMed ID: 27109565
[TBL] [Abstract][Full Text] [Related]
16. Development of HCV Therapeutic Vaccines Using Hp91 Peptide and Small Heat Shock Protein 20 as an Adjuvant.
Basirnejad M; Bolhassani A
Protein Pept Lett; 2018; 25(10):924-932. PubMed ID: 30255740
[TBL] [Abstract][Full Text] [Related]
17. Combination of cell penetrating peptides and heterologous DNA prime/protein boost strategy enhances immune responses against HIV-1 Nef antigen in BALB/c mouse model.
Kadkhodayan S; Jafarzade BS; Sadat SM; Motevalli F; Agi E; Bolhassani A
Immunol Lett; 2017 Aug; 188():38-45. PubMed ID: 28602843
[TBL] [Abstract][Full Text] [Related]
18. Strong HCV NS3/4a, NS4b, NS5a, NS5b-specific cellular immune responses induced in Rhesus macaques by a novel HCV genotype 1a/1b consensus DNA vaccine.
Latimer B; Toporovski R; Yan J; Pankhong P; Morrow MP; Khan AS; Sardesai NY; Welles SL; Jacobson JM; Weiner DB; Kutzler MA
Hum Vaccin Immunother; 2014; 10(8):2357-65. PubMed ID: 25424943
[TBL] [Abstract][Full Text] [Related]
19. Listeriolysin O immunogenetic adjuvant enhanced potency of hepatitis C virus NS3 DNA vaccine.
Pouriayevali MH; Bamdad T; Sadat SM; Sadeghi SA; Sabahi F; Mahdavi M; Aghasadeghi MR
IUBMB Life; 2019 Oct; 71(10):1645-1652. PubMed ID: 31298809
[TBL] [Abstract][Full Text] [Related]
20. The structural HCV genes delivered by MPG cell penetrating peptide are directed to enhance immune responses in mice model.
Mehrlatifan S; Mirnurollahi SM; Motevalli F; Rahimi P; Soleymani S; Bolhassani A
Drug Deliv; 2016 Oct; 23(8):2852-2859. PubMed ID: 26559939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
